All Events

Filter by

Event Date

Filter by Event Date

Done
Bethesda, Maryland
The NHLBI convened a working group in May 2013 to advise the NHLBI on new research directions needed to make progress toward achieving the development of bio-artificial hearts, which would address the shortcomings of mechanical circulatory support devices.
Bethesda, Maryland
In response to congressional encouragement, the NHLBI hosted in May 2013 a forum of representatives from federal government agencies to share information about current activities related to COPD and discuss opportunities for further improvement of the federal response to this serious public health problem.
November 28 - 29, 2012
Bethesda, Maryland
In November 2012, a working group recommended steps to expand our understanding of apheresis, which is a general term for treatments that remove harmful proteins, chemicals, or cells in the blood that contribute to disease.
National Institutes of Health (NIH)
Bethesda, Maryland
The 248th meeting of the National Heart, Lung, and Blood Advisory Council (NHLBAC) was convened at 12:39 p.m. on Wednesday, November 28, 2012, in Conference Room 6, C Wing, Building 31, National Institutes of Health (NIH), Bethesda, Maryland.
November 13 - 14, 2012
NIH
In November 2012, a working group discussed the current status of basic investigations in lung cell therapy, identified the scientific gaps in in our understanding of cell therapy in the treatment of lung diseases, and recommended scientific priorities that could advance lung cell therapy.
Johns Hopkins University
Rockville, MD
The first NHLBI Regional Innovation Conference was held on October 15, 2012 at Johns Hopkins University in Rockville, MD. There were approximately 150 attendees including NHLBI small-business awardees and investors from leading companies in the mid-Atlantic region. Thanks to our partner, Biohealth Innovation, Inc (BHI) for making this event a success.